跳至主要内容
临床试验/NCT05685914
NCT05685914尚未招募不适用

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

Peking University Cancer Hospital & Institute1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
30-day mortality

研究概览

简要总结

The goal of this observational study is to determine 30-day mortality and post endoscopic surgery complications in patients with COVID-19 infection who undergo endoscopic surgery.This results will inform future risk stratification, decision making and improve patient's clinical care.This study is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing any type of endoscopic surgery in an operating theatre and these patients had COVID-19 infection either at the time of surgery or within 30 days of surgery.

排除标准

  • If COVID-19 infection is diagnosed >30 days after discharge, the patient should not be included.

结局指标

主要结局

30-day mortality

时间窗: 30 days

Death up to 30-days post surgery

次要结局

  • postoperative complications(30 days)

研究者

发起方
Peking University Cancer Hospital & Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验